Curcumin induces apoptosis in tumor necrosis factor-alpha-treated HaCaT cells

被引:42
作者
Sun, Jun [1 ]
Han, Jinzhao [1 ]
Zhao, Yi [1 ]
Zhu, Quangang [1 ]
Hu, Jinhong [1 ]
机构
[1] Second Mil Med Univ, Changhai Hosp, Dept Pharm, Shanghai 200433, Peoples R China
基金
中国国家自然科学基金;
关键词
Curcumin; Apoptosis; Keratinocyte; TNF alpha; TRAIL receptor; NF-KAPPA-B; HUMAN HEPATOMA-CELLS; HUMAN KERATINOCYTES; TNF-ALPHA; UP-REGULATION; EXPRESSION; PSORIASIS; TRAIL; ACTIVATION; MATURATION;
D O I
10.1016/j.intimp.2012.03.025
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Psoriasis is a benign, chronic skin disease characterized by keratinocyte hyperproliferation and abnormal differentiation. Curcumin, a selective phosphorylase kinase inhibitor, is a natural phytochemical present in turmeric. Curcumin has been confirmed to have anti-inflammatory properties as well as the ability to inhibit proliferation and decrease the expression of pro-inflammatory cytokines in psoriatic keratinocytes. However. the pro-apoptotic effect of curcumin in keratinocytes remains unclear. In the present study, we investigated the effect of curcumin on apoptosis induction in TNF-alpha-treated HaCaT cells. These results show that curcumin exhibited a significant pro-apoptotic effect on HaCaT cells only in the presence of TNF-alpha and/or TRAIL The pro-apoptotic effect of curcumin resulted from the increased expression of TRAIL-R1/R2 and the decreased expression of anti-apoptotic proteins. Our results indicate that both curcumin and TNF-alpha upregulated the expression of TRAIL-R1/R2. In addition, the expression of anti-apoptotic proteins (IAP1, IAP2, Bcl-X-L) was upregulated by INF-alpha but suppressed by curcumin in HaCaT cells. Because these proteins are regulated by NF-kappa B, we examined the role of curcumin in NF-kappa B activation. As expected, curcumin inhibited TNF-alpha-induced activation of NF-kappa B, including NF-kappa B-P65. Curcumin also inhibited the TNF-alpha-induced production of IL-6/1L8 in HaCaT cells. These results imply that curcumin-induced apoptosis of HaCaT cells only occurs when TNF-alpha or/and TRAIL are present. Therefore, we believe that curcumin is able to reverse the anti-apoptotic function of TNF-alpha in HaCaT cells and thus expect curcumin to be successful in the treatment of psoriasis. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:170 / 174
页数:5
相关论文
共 29 条
  • [1] Aggarwal BB, 2005, CANC TREAT, V126, P103, DOI 10.1007/0-387-24361-5_5
  • [2] Serum levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17 and IL-18 in patients with active psoriasis and correlation with disease severity
    Arican, O
    Aral, M
    Sasmaz, S
    Ciragil, P
    [J]. MEDIATORS OF INFLAMMATION, 2005, (05) : 273 - 279
  • [3] Campbell Frederick C, 2005, Future Oncol, V1, P405, DOI 10.1517/14796694.1.3.405
  • [4] Cassano N, 2006, INT J IMMUNOPATH PH, V19, P237
  • [5] Cho JW, 2007, INT J MOL MED, V19, P469
  • [6] Chemopreventive and therapeutic effects of curcumin
    Duvoix, A
    Blasius, R
    Delhalle, S
    Schnekenburger, M
    Morceau, F
    Henry, E
    Dicato, M
    Diederich, M
    [J]. CANCER LETTERS, 2005, 223 (02) : 181 - 190
  • [7] ELEVATED TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) BIOLOGICAL-ACTIVITY IN PSORIATIC SKIN-LESIONS
    ETTEHADI, P
    GREAVES, MW
    WALLACH, D
    ADERKA, D
    CAMP, RDR
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1994, 96 (01) : 146 - 151
  • [8] Innate and adaptive immunity and the pathophysiology of psoriasis
    Gaspari, AA
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : S67 - S80
  • [9] Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene
    Guan, BX
    Yue, P
    Clayman, GL
    Sun, SY
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2001, 188 (01) : 98 - 105
  • [10] Activation of nuclear factor κB by different agents -: Influence of culture conditions in a cell-based assay
    Hellweg, Christine E.
    Arenz, Andrea
    Bogner, Susanne
    Schmitz, Claudia
    Baumstark-Khan, Christa
    [J]. SIGNAL TRANSDUCTION PATHWAYS, PT B: STRESS SIGNALING AND TRANSCRIPTIONAL CONTROL, 2006, 1091 : 191 - 204